Detalles de la búsqueda
1.
3-year clinical follow-up of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with de novo coronary artery lesions: the SPIRIT II trial (Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery Lesions).
JACC Cardiovasc Interv
; 2(12): 1190-8, 2009 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-20129545
Resultados
1 -
1
de 1
1
Próxima >
>>